Allogeneic Transplantation for Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia

Blood. 2009 Dec 23; Epub ahead of print, MR Litzow, S Tarima, WS Perez, BJ Bolwell, MS Cairo, BM Camitta, CS Cutler, M de Lima, JF DiPersio, RP Gale, A Keating, HM Lazarus, S Luger, DI Marks, RT Maziarz, PL McCarthy, MC Pasquini, GL Phillips, JD Rizzo, J Sierra, MS Tallman, DJ Weisdorf

Abstract

Outcomes after allogeneic transplant for patients with therapy-related myelodysplastic syndrome and acute myeloid leukemia were encouraging. This large study also identified risk factors that adversely affected disease-free survival and overall survival. Such data may be useful in selecting patients most likely to benefit from allogeneic transplant.